First Regular Session | 75th General Assembly
Colorado General AssemblyPresented to the Joint State, Veterans, and Military Affairs Committee at its December 16, 2016, meeting.
Presented to the State, Veterans, and Military Affairs Committee at its December 16, 2016, meeting.
Colorado receives annual payments from tobacco manufacturers as part of the Tobacco Master Settlement Agreement. In April 2016, the state received $92.3 million. This memorandum presents the distribution of the 2016 payment and forecasts payments through 2019.
This issue brief outlines Colorado's efforts to address issues associated with persons with mental illness in the criminal justice system.
The U.S. Constitution guarantees each citizen the right to a fair trial, which includes the right to be present at the trial, able to understand the nature of the proceedings, and able to participate in his or her defense. Whether the defendant’s mental health impaired his or her ability to...
This memorandum provides an overview of the recovery of damages for loss of use by rental vehicle companies and various state laws that prohibit or limit the recovery of these damages.
This issue brief provides an overview of state laws related to insurance guaranty funds. Insurance guaranty funds are designed to avoid excessive delays in payment and financial losses to insurance claimants or policyholders because of the insolvency of an insurer.
The Legislative Council Staff's Health Care Resource Book is intended to serve as a reference guide for information on some of Colorado's major health care issues and programs. The book is divided into two sections.
The first section covers health care spending; private health insurance...
This memorandum provides an overview of the 2017 membership of the Opioid and Other Substance Use Disorders Interim Study Committee, the origin and charge of the committee, bill request deadlines and procedures, and information regarding committee staff and the committee website. Information is...
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.